Technical knowledge for buyers who want to understand, not just order

We are a GMP-certified manufacturer of standardized botanical ingredients. Our factory, our laboratory — fully owned, fully controlled, fully accountable to you.

4

Industries covered: nutra, pharma, cosmo, vet

30+

Technical articles, guides & white papers

12

Regulatory market updates across key regions

  • All
  • Nutraceuticals
Dandelion
Nutraceuticals

What is Dandelion Extract? A Complete Guide to Benefits, Sourcing and Manufacturing

1. What is Dandelion Extract? Dandelion Extract is a highly concentrated, standardized botanical powder derived from the dried whole plant (or specifically the roots/leaves) of Taraxacum mongolicum Hand.-Mazz. or Taraxacum officinale. Utilizing modern physical extraction, precision filtration, and spray-drying processes, ...
Scutellaria
Nutraceuticals

What is Scutellaria Extract? A Complete Guide to Benefits, Sourcing and Manufacturing

1. What is Scutellaria Extract? Scutellaria Extract is a highly purified, standardized bioactive powder derived from the dried roots of Scutellaria baicalensis Georgi. Through advanced physical extraction, separation, and purification technologies, the inert plant fibers are removed, and its core ...
honeysuckle
Nutraceuticals

What is Honeysuckle Extract? A Complete Guide to Benefits, Sourcing and Manufacturing

1. What is Honeysuckle Extract? Honeysuckle Extract is a highly purified, standardized botanical ingredient derived from the dried flower buds of Lonicera japonica Thunb. Through state-of-the-art physical extraction, resin separation, and low-temperature spray drying, the natural plant matrix is refined ...

Free downloads

Key regulations across all four industries

Updated quarterly. Covers regulations most relevant to botanical ingredient buyers in nutraceuticals, pharmaceuticals, cosmetics, and veterinary markets. 

EU Cosmetics Regulation 1223/2009 — Annex Updates

The EU’s framework for cosmetic product safety. Annex II (prohibited substances) and Annex III (restricted substances) are updated regularly. Several botanical extracts with genotoxic alkaloids (e.g. pyrrolizidine alkaloids in comfrey) have moved to restricted or prohibited status since 2022.

Ongoing amendments · Present

Impact on buyers

Request updated Annex compliance letters for any botanical extract sourced for EU cosmetic use. We provide Annex status certificates with every order.

EU Novel Food Regulation 2015/2283 — Botanical Extracts

Several botanical extracts now require Novel Food authorisation before sale as food supplements in the EU — including ashwagandha (currently under review by EFSA), certain peptide extracts, and concentrated polyphenol fractions not traditionally consumed at supplement levels.

Active · EFSA reviews ongoing

Impact on buyers

Verify Novel Food status before launching any extract in EU. Ashwagandha and certain adaptogens are in EFSA review. We track status for all ingredients we supply.

FDA Botanical Drug Guidance for Industry (2016, 2023 update)

FDA’s 2023 updated guidance clarifies API characterization requirements for botanical drugs entering IND/NDA pathways. Supplier documentation — including full botanical identification, standardization method, and batch-to-batch consistency data — is now explicitly required at IND stage.

2023 revision in effect

Impact on buyers

Pharmaceutical clients sourcing botanical APIs for drug development must request enhanced supplier documentation packages from us, including ICH Q11-aligned technical files.

FDA 21 CFR Part 111 — Dietary Supplement cGMP

All dietary supplement manufacturers (and their ingredient suppliers) must comply with current Good Manufacturing Practice. Identity testing of botanical ingredients — confirming genus, species, and part — is a legally mandated step, not optional.

In force since: June 2010

Impact on buyers

Request botanical identity certificates (DNA barcoding or TLC fingerprint) from every ingredient supplier. We include identity testing in all standard CoA packages.

EU Regulation 2019/6 — Veterinary Medicinal Products

Prohibition on antibiotic use for growth promotion or routine prophylaxis across all EU member states. Effective January 2022. Applies to all production species. Botanical alternatives to AGPs now required for compliant EU production programs.

In force since: January 2022

Impact on buyers

Full documentation of botanical health programs now part of EU farm assurance schemes. We provide species-specific compliance dossiers.

Heavy Metal Compliance — Global Safety Standards

Botanical extracts naturally absorb trace minerals from their growing environment. To ensure product safety across all applications, controlling primary heavy metals—Lead (Pb), Cadmium (Cd), Arsenic (As), and Mercury (Hg)—is a mandatory compliance step for international trade, particularly in strict markets like the EU and US. Through rigorous “Dao-di” raw material selection and standardized processing, we strictly control these trace elements within safe thresholds.

Pharma: mandatory · Cosmetics: voluntary adoption
 

Impact on buyers

Specify your regional heavy metal limits in your sourcing agreements. We provide transparent, standardized testing for the “Big 4” heavy metals (Pb, Cd, As, Hg) in our standard Certificate of Analysis (CoA) to ensure your final formulations meet local safety regulations.

Put the knowledge to work

Same botanical source,
four different industries —
let's match the right spec

Whether you’re formulating a cosmetic serum, a supplement capsule, a botanical API, or a veterinary feed program — our technical team will help you identify the right extract grade, documentation package, and regulatory pathway for your market.

Send us a message

We reply within 1 business day with pricing, lead time, and sample tracking number.